Terms: = Endocrine gland cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Prognosis
37 results:
1. CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells.
Samain R; Maiques O; Monger J; Lam H; Candido J; George S; Ferrari N; KohIhammer L; Lunetto S; Varela A; Orgaz JL; Vilardell F; Olsina JJ; Matias-Guiu X; Sarker D; Biddle A; Balkwill FR; Eyles J; Wilkinson RW; Kocher HM; Calvo F; Wells CM; Sanz-Moreno V
Sci Adv; 2023 Oct; 9(42):eadi0244. PubMed ID: 37851808
[TBL] [Abstract] [Full Text] [Related]
2. Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma.
Xiao Y; Zhang B; Cloyd JM; Xu G; Du S; Mao Y; Pawlik TM
Surg Oncol; 2022 Sep; 44():101849. PubMed ID: 36116415
[TBL] [Abstract] [Full Text] [Related]
3. Radioactive iodine in low- to intermediate-risk papillary thyroid cancer.
Zhao H; Gong Y
Front Endocrinol (Lausanne); 2022; 13():960682. PubMed ID: 36034423
[TBL] [Abstract] [Full Text] [Related]
4. HNRNPC regulates rhoa to induce DNA damage repair and cancer-associated fibroblast activation causing radiation resistance in pancreatic cancer.
Xia N; Yang N; Shan Q; Wang Z; Liu X; Chen Y; Lu J; Huang W; Wang Z
J Cell Mol Med; 2022 Apr; 26(8):2322-2336. PubMed ID: 35277915
[TBL] [Abstract] [Full Text] [Related]
5. Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced Ovarian cancer: A Clinical Study of 100 Patients.
Zhang J; Li XB; Ji ZH; Ma R; Bai WP; Li Y
Biomed Res Int; 2021; 2021():5533134. PubMed ID: 34258265
[TBL] [Abstract] [Full Text] [Related]
6. β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer.
Tocci P; Cianfrocca R; Di Castro V; Rosanò L; Sacconi A; Donzelli S; Bonfiglio S; Bucci G; Vizza E; Ferrandina G; Scambia G; Tonon G; Blandino G; Bagnato A
Nat Commun; 2019 Jul; 10(1):3196. PubMed ID: 31324767
[TBL] [Abstract] [Full Text] [Related]
7. La-Related Protein 4 as a Suppressor for Motility of Ovarian cancer Cells.
Egiz M; Usui T; Ishibashi M; Zhang X; Shigeta S; Toyoshima M; Kitatani K; Yaegashi N
Tohoku J Exp Med; 2019 Jan; 247(1):59-67. PubMed ID: 30686809
[TBL] [Abstract] [Full Text] [Related]
8. Regulation of extracellular matrix degradation and metastatic spread by IQGAP1 through endothelin-1 receptor signalling in ovarian cancer.
Chellini L; Caprara V; Spadaro F; Sestito R; Bagnato A; Rosanò L
Matrix Biol; 2019 Aug; 81():17-33. PubMed ID: 30367951
[TBL] [Abstract] [Full Text] [Related]
9. Association Between Inherited Germline Mutations in cancer Predisposition Genes and Risk of Pancreatic cancer.
Hu C; Hart SN; Polley EC; Gnanaolivu R; Shimelis H; Lee KY; Lilyquist J; Na J; Moore R; Antwi SO; Bamlet WR; Chaffee KG; DiCarlo J; Wu Z; Samara R; Kasi PM; McWilliams RR; Petersen GM; Couch FJ
JAMA; 2018 Jun; 319(23):2401-2409. PubMed ID: 29922827
[TBL] [Abstract] [Full Text] [Related]
10. Overall Survival of Papillary Thyroid Carcinoma Patients: A Single-Institution Long-Term Follow-Up of 5897 Patients.
Ito Y; Miyauchi A; Kihara M; Fukushima M; Higashiyama T; Miya A
World J Surg; 2018 Mar; 42(3):615-622. PubMed ID: 29349484
[TBL] [Abstract] [Full Text] [Related]
11. Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer.
Li H; Wang X; Wen C; Huo Z; Wang W; Zhan Q; Cheng D; Chen H; Deng X; Peng C; Shen B
Mol Cancer; 2017 Nov; 16(1):169. PubMed ID: 29121972
[TBL] [Abstract] [Full Text] [Related]
12. Rac GTPase activating protein 1 promotes oncogenic progression of epithelial ovarian cancer.
Wang C; Wang W; Liu Y; Yong M; Yang Y; Zhou H
Cancer Sci; 2018 Jan; 109(1):84-93. PubMed ID: 29095547
[TBL] [Abstract] [Full Text] [Related]
13. Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients.
Hang J; Xue P; Yang H; Li S; Chen D; Zhu L; Huang W; Ren S; Zhu Y; Wang L
Sci Rep; 2017 Jun; 7(1):2993. PubMed ID: 28592881
[TBL] [Abstract] [Full Text] [Related]
14. Crizotinib, a MET inhibitor, prevents peritoneal dissemination in pancreatic cancer.
Takiguchi S; Inoue K; Matsusue K; Furukawa M; Teramoto N; Iguchi H
Int J Oncol; 2017 Jul; 51(1):184-192. PubMed ID: 28498406
[TBL] [Abstract] [Full Text] [Related]
15. Expression of orphan GPR56 correlates with tumor progression in human epithelial ovarian cancer.
Liu Z; Huang Z; Yang W; Li Z; Xing S; Li H; Hu B; Li P
Neoplasma; 2017; 64(1):32-39. PubMed ID: 27881002
[TBL] [Abstract] [Full Text] [Related]
16. Evaluation of Prognostic Factors Associated With Differentiated Thyroid Carcinoma With Pulmonary Metastasis.
Qutbi M; Shafeie B; Amoui M; Tabeie F; Azizmohammadi Z; Mahmoud-Pashazadeh A; Javadi H; Assadi M; Asli IN
Clin Nucl Med; 2016 Dec; 41(12):917-921. PubMed ID: 27764045
[TBL] [Abstract] [Full Text] [Related]
17. ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of the cancer cells.
Fukushima H; Yasumoto M; Ogasawara S; Akiba J; Kitasato Y; Nakayama M; Naito Y; Ishida Y; Okabe Y; Yasunaga M; Horiuchi H; Sakamoto E; Itadani H; Mizuarai S; Oie S; Yano H
Mol Cancer; 2016 May; 15(1):32. PubMed ID: 27145964
[TBL] [Abstract] [Full Text] [Related]
18. Ceramide 1-phosphate regulates cell migration and invasion of human pancreatic cancer cells.
Rivera IG; Ordoñez M; Presa N; Gangoiti P; Gomez-Larrauri A; Trueba M; Fox T; Kester M; Gomez-Muñoz A
Biochem Pharmacol; 2016 Feb; 102():107-119. PubMed ID: 26707801
[TBL] [Abstract] [Full Text] [Related]
19. Elevated GRP78 expression is associated with poor prognosis in patients with pancreatic cancer.
Niu Z; Wang M; Zhou L; Yao L; Liao Q; Zhao Y
Sci Rep; 2015 Nov; 5():16067. PubMed ID: 26530532
[TBL] [Abstract] [Full Text] [Related]
20. Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian cancer: A Cohort Study.
Kolomeyevskaya NV; Szender JB; Zirpoli G; Minlikeeva A; Friel G; Cannioto RA; Brightwell RM; Grzankowski KS; Moysich KB
Int J Gynecol Cancer; 2015 Nov; 25(9):1587-92. PubMed ID: 26273932
[TBL] [Abstract] [Full Text] [Related]
[Next]